Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,098 | -3,398 | 5,350 | -22,270 | -9,410 |
| Depreciation Amortization | 436 | 292 | 27 | 30 | 20 |
| Other Working Capital | -172 | 6 | -698 | -1,350 | -2,270 |
| Other Operating Activity | 565 | 455 | -7,995 | 12,980 | 3,330 |
| Operating Cash Flow | $-3,269 | $-2,646 | $-3,315 | $-10,610 | $-8,330 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -10 | -10 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-10 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,721 | 2,721 | N/A | N/A | N/A |
| Debt Repayment | -143 | -95 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 157 | 8,939 | N/A |
| Other Financing Activity | 99 | 89 | 0 | 9,201 | 12,650 |
| Financing Cash Flow | $2,677 | $2,715 | $157 | $18,140 | $12,650 |
| Beginning Cash Position | 980 | 980 | 8,770 | 1,260 | 1,260 |
| End Cash Position | 388 | 1,050 | 5,612 | 8,760 | 5,560 |
| Net Cash Flow | $-592 | $70 | $-3,158 | $7,500 | $4,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,269 | -2,646 | -3,315 | -10,610 | -8,330 |
| Capital Expenditure | N/A | N/A | N/A | -18 | N/A |
| Free Cash Flow | -3,269 | -2,646 | -3,315 | -10,628 | -8,330 |